Article

Household transmission of pandemic (H1N1) 2009, San Antonio, Texas, USA, April-May 2009.

Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop C12, Atlanta, GA 30333, USA.
Emerging Infectious Diseases (Impact Factor: 7.33). 04/2010; 16(4):631-7. DOI: 10.3201/eid1604.091658
Source: PubMed

ABSTRACT To assess household transmission of pandemic (H1N1) 2009 in San Antonio, Texas, USA, during April 15-May 8, 2009, we investigated 77 households. The index case-patient was defined as the household member with the earliest onset date of symptoms of acute respiratory infection (ARI), influenza-like illness (ILI), or laboratory-confirmed pandemic (H1N1) 2009. Median interval between illness onset in index and secondary case-patients was 4 days (range 1-9 days); the index case-patient was likely to be < or =18 years of age (p = 0.034). The secondary attack rate was 4% for pandemic (H1N1) 2009, 9% for ILI, and 13% for ARI. The secondary attack rate was highest for children <5 years of age (8%-19%) and lowest for adults > or =50 years of age (4%-12%). Early in the outbreak, household transmission primarily occurred from children to other household members and was lower than the transmission rate for seasonal influenza.

Download full-text

Full-text

Available from: Shannon Emery, Jul 07, 2015
0 Followers
 · 
164 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: During an influenza pandemic, a substantial proportion of transmission is thought to occur in households. We used data on influenza progression in individuals and their contacts collected by the City of Milwaukee Health Department (MHD) to study the transmission of pandemic influenza A/H1N1 virus in 362 households in Milwaukee, WI, and the effects of oseltamivir treatment and chemoprophylaxis. 135 households had chronological information on symptoms and oseltamivir usage for all household members. The effect of oseltamivir treatment and other factors on the household secondary attack rate was estimated using univariate and multivariate logistic regression with households as the unit of analysis. The effect of oseltamivir treatment and other factors on the individual secondary attack rate was estimated using univariate and multivariate logistic regression with individual household contacts as the unit of analysis, and a generalized estimating equations approach was used to fit the model to allow for clustering within households. Oseltamivir index treatment on onset day or the following day (early treatment) was associated with a 42% reduction (OR: 0.58, 95% CI: 0.19, 1.73) in the odds of one or more secondary infections in a household and a 50% reduction (OR: 0.5, 95% CI: 0.17, 1.46) in the odds of a secondary infection in individual contacts. The confidence bounds are wide due to a small sample of households with early oseltamivir index usage - in 29 such households, 5 had a secondary attack. Younger household contacts were at higher risk of infection (OR: 2.79, 95% CI: 1.50-5.20). Early oseltamivir treatment may be beneficial in preventing H1N1pdm influenza transmission; this may have relevance to future control measures for influenza pandemics. Larger randomized trials are needed to confirm this finding statistically.
    BMC Infectious Diseases 07/2010; 10(1):211. DOI:10.1186/1471-2334-10-211 · 2.56 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Influenza virus infection of humans results in a respiratory disease that ranges in severity from sub-clinical infection to primary viral pneumonia that can result in death. The clinical effects of infection vary with the exposure history, age and immune status of the host, and also the virulence of the influenza strain. In humans, the virus is transmitted through either aerosol or contact-based transfer of infectious respiratory secretions. As is evidenced by most zoonotic influenza virus infections, not all strains that can infect humans are able to transmit from person-to-person. Animal models of influenza are essential to research efforts aimed at understanding the viral and host factors that contribute to the disease and transmission outcomes of influenza virus infection in humans. These models furthermore allow the pre-clinical testing of antiviral drugs and vaccines aimed at reducing morbidity and mortality in the population through amelioration of the virulence or transmissibility of influenza viruses. Mice, ferrets, guinea pigs, cotton rats, hamsters and macaques have all been used to study influenza viruses and therapeutics targeting them. Each model presents unique advantages and disadvantages, which will be discussed herein.
    Viruses 08/2010; 2(8):1530-1563. DOI:10.3390/v20801530 · 3.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To assess household transmission of pandemic influenza A (H1N1) and effectiveness of postexposure prophylaxis (PEP) of antiviral drugs among household contacts of patients during the first pandemic influenza A (H1N1) outbreak in Osaka, Japan in May 2009. Active surveillance of patients and their families was conducted. Public Health Center staff visited each home with an infected patient and advised every household member with regard to precautionary measures, and PEP was provided to household contacts to prevent secondary infection. We analyzed the effectiveness of PEP and characteristics of secondary infection. The secondary attack rate (SAR) among household contacts was 3.7%. The SAR among household contacts without PEP was 26.1%. However, the SAR among those with PEP was 0.6%. Only two of 331 household contacts with PEP became infected. One of the two was infected with an oseltamivir-resistant strain. Analysis of SAR by age group showed that those under 20 years of age were at higher risk than those over 20 (relative risk [RR] = 7.9; 95% confidence interval [CI] = 2.24-27.8). Significant differences with respect to sex, number of household contacts, and use of antiviral medications in the index cases were not observed. Our present results indicate that PEP is effective for preventing secondary H1N1 infection among household contacts.
    The Journal of infection 10/2010; 61(4):284-8. DOI:10.1016/j.jinf.2010.06.019 · 4.02 Impact Factor